This wiki has undergone a migration to Confluence found Here
CSCR-105-PtSafety-Link to Product
Jump to navigation
Jump to search
Back to Clinical Statement Change Requests page.
Submitted by: Mead Walker | Revision date: <<Revision Date>> |
Submitted date: 29-Jun-09 | Change request ID: CSCR-105 |
Issue
- The current RMIM for adverse event reporting, the ICSR includes a model that is based on the clinical statement, but it is not a legal restriction of that model. We would like, to meet ballot comments and for other reasons, to make the model known as "Product Reporting Relevant Information" such a legal restriction, and, perhaps, to replace it with the clinical statement CMET.
- However, in order to do that, we the current clinical statement references to consumable items in substance administration, to products in Supply, to devices in procedure to be expanded to support the R_ProductReportable CMET - COCT_RM620000UV. In addition, we would like to see a product participation added to Act to support the reporting of product defects (detected outside of a substance administration or procedure.
Recommendation
- That the needed references to the R_ProductReportable RMIM be added to the clinical statement.
Rationale
- This step is needed in order for the clinical statement model to support the needs of adverse event and product defect reporting.
Discussion
Recommended Action Items
- Acceptance of the recommendations listed above and modification of the clinical statement model.